Molnár T - Search Results

1

Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort Study.

Albshesh A, Taylor J, Savarino EV, Truyens M, Armuzzi A, Ribaldone DG, Shitrit AB, Fibelman M, Molander P, Liefferinckx C, Nancey S, Korani M, Rutka M, Barreiro-de Acosta M, Domislovic V, Suris G, Eriksson C, Alves C, Mpitouli A, di Jiang C, Tepeš K, Coletta M, Foteinogiannopoulou K, Gisbert JP, Amir-Barak H, Attauabi M, Seidelin J, Afif W, Marinelli C, Lobaton T, Pugliese D, Maharshak N, Cremer A, Limdi JK, Molnár T, Otero-Alvarin B, Krznaric Z, Magro F, Karmiris K, Raine T, Drobne D, Koutroubakis I, Chaparro M, Yanai H, Burisch J, Kopylov U. Albshesh A, et al. Among authors: molnar t. J Clin Med. 2021 Jun 29;10(13):2914. doi: 10.3390/jcm10132914. J Clin Med. 2021. PMID: 34209880 Free PMC article.

2

Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?

Rutka M, Milassin Á, Szepes Z, SzŰcs M, Nyári T, Bálint A, Bor R, Molnár T, Farkas K. Rutka M, et al. Among authors: molnar t. Scand J Gastroenterol. 2015 Aug;50(8):985-90. doi: 10.3109/00365521.2015.1018313. Epub 2015 Mar 2. Scand J Gastroenterol. 2015. PMID: 25733077

3

Efficacy of the new infliximab biosimilar CT-P13 induction therapy in Crohn's disease and ulcerative colitis - experiences from a single center.

Farkas K, Rutka M, Bálint A, Nagy F, Bor R, Milassin Á, Szepes Z, Molnár T. Farkas K, et al. Among authors: molnar t. Expert Opin Biol Ther. 2015;15(9):1257-62. doi: 10.1517/14712598.2015.1064893. Epub 2015 Jul 2. Expert Opin Biol Ther. 2015. PMID: 26134250

4

Prospective Comparison of Magnetic Resonance Imaging, Transrectal and Transperineal Sonography, and Surgical Findings in Complicated Perianal Crohn Disease.

Bor R, Farkas K, Bálint A, Szűcs M, Ábrahám S, Milassin Á, Rutka M, Nagy F, Milassin P, Szepes Z, Molnár T. Bor R, et al. Among authors: molnar t. J Ultrasound Med. 2016 Nov;35(11):2367-2372. doi: 10.7863/ultra.15.09043. Epub 2016 Sep 14. J Ultrasound Med. 2016. PMID: 27629757

5

Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease.

Bor R, Farkas K, Fábián A, Bálint A, Milassin Á, Rutka M, Matuz M, Nagy F, Szepes Z, Molnár T. Bor R, et al. Among authors: molnar t. PLoS One. 2017 Mar 31;12(3):e0172916. doi: 10.1371/journal.pone.0172916. eCollection 2017. PLoS One. 2017. PMID: 28362851 Free PMC article.

6

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation [ECCO]. Harbord M, et al. Among authors: molnar t. J Crohns Colitis. 2017 Jul 1;11(7):769-784. doi: 10.1093/ecco-jcc/jjx009. J Crohns Colitis. 2017. PMID: 28513805 No abstract available.

7

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases.

Gonczi L, Kurti Z, Rutka M, Vegh Z, Farkas K, Lovasz BD, Golovics PA, Gecse KB, Szalay B, Molnar T, Lakatos PL. Gonczi L, et al. Among authors: molnar t. BMC Gastroenterol. 2017 Aug 8;17(1):97. doi: 10.1186/s12876-017-0654-1. BMC Gastroenterol. 2017. PMID: 28789636 Free PMC article.

8

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center.

Farkas K, Rutka M, Ferenci T, Nagy F, Bálint A, Bor R, Milassin Á, Fábián A, Szántó K, Végh Z, Kürti Z, Lakatos PL, Szepes Z, Molnár T. Farkas K, et al. Among authors: molnar t. Expert Opin Biol Ther. 2017 Nov;17(11):1325-1332. doi: 10.1080/14712598.2017.1363885. Epub 2017 Aug 18. Expert Opin Biol Ther. 2017. PMID: 28819991

9

Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.

Szántó K, Nyári T, Bálint A, Bor R, Milassin Á, Rutka M, Fábián A, Szepes Z, Nagy F, Molnár T, Farkas K. Szántó K, et al. Among authors: molnar t. PLoS One. 2018 Jul 30;13(7):e0200824. doi: 10.1371/journal.pone.0200824. eCollection 2018. PLoS One. 2018. PMID: 30059523 Free PMC article.

10

Lupus-like reactions in patients with inflammatory bowel disease: a little bit different data from another center.

Pigniczki D, Rutka M, Farkas K, Molnar T. Pigniczki D, et al. Among authors: molnar t. Scand J Gastroenterol. 2019 Dec;54(12):1498. doi: 10.1080/00365521.2019.1690038. Epub 2019 Dec 9. Scand J Gastroenterol. 2019. PMID: 31818162 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

858 results

Search Page